There's a clinical trial of both Zytiga and Xtandi together that you may be eligible for. It's Phase II, so you are guaranteed to get both:A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients
These are both proven to increase survival.
The other clinical trial I'd be eager to get into would be for Cabozantanib. It's had spectacular results so far:Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to BoneCabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate CancerMagnetic Resonance Imaging in Measuring the Effect of Cabozantinib on Bone Metastases in Patients With Castrate Resistant Prostate CancerCabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer
They are all Phase I or Phase II studies, which means you are guaranteed to get the drug.
•3rd biopsy (4/2010):
PSA=7.3, prostate volume=55cc, 8 of 17 cores G6 5-35% involvement
•SBRT (5x8Gy) at UCLA, 10/2010 at age 57
•PSA since treatment:
+3 mos:3.9 +4 mos:3.5 +7 mos:3.0 +10 mos:3.7 +13 mos:3.6 +19 mos:1.18 +23 mos:1.29 +29 mos:.37
• Side Effects of treatment:
+2 wks: Grade 1 urinary & rectal last 1 wk
+1 yr: Grade 1 urinary last 2 months